TARIQ SHAFI to Risk Assessment
This is a "connection" page, showing publications TARIQ SHAFI has written about Risk Assessment.
Connection Strength
1.083
-
Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES). BMC Nephrol. 2019 04 25; 20(1):138.
Score: 0.301
-
CKD to ESRD transition: does assessment of kidney function matter? Nephrol Dial Transplant. 2017 01 01; 32(1):1-3.
Score: 0.256
-
Individualized Risk of CKD Progression among US Adults. J Am Soc Nephrol. 2024 Aug 01; 35(8):1076-1083.
Score: 0.107
-
Race and Mortality in CKD and Dialysis: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2020 03; 75(3):394-403.
Score: 0.078
-
Association of NTproBNP and cTnI with outpatient sudden cardiac death in hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study. BMC Nephrol. 2016 Feb 20; 17:18.
Score: 0.060
-
Serum ?-trace protein and risk of mortality in incident hemodialysis patients. Clin J Am Soc Nephrol. 2012 Sep; 7(9):1435-45.
Score: 0.047
-
Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY. J Diabetes Complications. 2026 Apr; 40(4):109274.
Score: 0.030
-
Designing an Implementable Clinical Prediction Model for Near-Term Mortality and Long-Term Survival in Patients on Maintenance Hemodialysis. Am J Kidney Dis. 2024 07; 84(1):73-82.
Score: 0.026
-
Risk Prediction Models for Atherosclerotic Cardiovascular Disease in Patients with Chronic Kidney Disease: The CRIC Study. J Am Soc Nephrol. 2022 03; 33(3):601-611.
Score: 0.023
-
Hypertensive Diseases in Pregnancy and Kidney Function Later in Life: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study. Mayo Clin Proc. 2022 01; 97(1):78-87.
Score: 0.022
-
Kidney Disease Symptoms before and after Kidney Transplantation. Clin J Am Soc Nephrol. 2021 07; 16(7):1083-1093.
Score: 0.022
-
Antihyperglycemic Therapies With Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns Within an Academic Medical Center. J Cardiovasc Pharmacol. 2020 09; 76(3):313-320.
Score: 0.021
-
Adiposity, Physical Function, and Their Associations With Insulin Resistance, Inflammation, and Adipokines in CKD. Am J Kidney Dis. 2021 01; 77(1):44-55.
Score: 0.021
-
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. J Am Heart Assoc. 2019 08 06; 8(15):e012200.
Score: 0.019
-
Risks of Adverse Events in Advanced CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis. 2017 Sep; 70(3):337-346.
Score: 0.016
-
Rationale and design for the Predictors of Arrhythmic and Cardiovascular Risk in End Stage Renal Disease (PACE) study. BMC Nephrol. 2015 Apr 24; 16:63.
Score: 0.014
-
Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. 2014 Apr; 9(4):745-55.
Score: 0.013
-
Prevention of hypertension and its complications: theoretical basis and guidelines for treatment. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S92-8.
Score: 0.006